OP: @[email protected]

Scotland’s RSV (respiratory syncytial virus) vaccination programme has resulted in a 62% reduction in related hospitalisations among the eligible age group. The findings were published in the Lancet in a Study by Public Health Scotland (PHS), in collaboration with the University of Strathclyde. RSV is a common and highly infectious respiratory virus that affects the breathing system and can be very serious for those who are at the highest risk of serious illness from the infection, including older adults.